Background In Poland, the rate of cesarean birth (CB) is 43%, which is much higher than the European average of 27%. Optimizing the CB birth rate is of critical importance, especially among women with low‐risk pregnancies. However, the determinants of cesarean preference among low‐risk women in Poland have not been well explored. Methods This cross‐sectional study included 1011 pregnant women and aimed to identify associations between selected determinants of women's preferences for CB vs. vaginal birth (VB) in Poland. A descriptive questionnaire was distributed online, and a theoretical model was validated against empirically gathered data. Group comparisons were performed using the Welch t test for continuous data or chi‐square test for categorical data. All statistical analyses were performed using R (R Core Team, 2018). Results The mean age of women preferring CB (30.46 years) was 1.25 years higher than that of women preferring VB (29.21 years). Pregnant women who expressed a preference for CB tended to be multigravid, inhabited cities, and were characterized by higher levels of anxiety and depression. Moreover, the majority of women who underwent a previous CB asserted their intention to repeat the procedure for the current pregnancy. Conclusions The primary factors that were correlated with high CB preference among the low‐risk group included age, previous childbirth experiences, and anxiety. The underlying reasons that drive birth preferences remain poorly understood. However, women who have previously undergone difficult childbirth experiences and are afraid of pain require specialized care.
StreszczenieWstęp: Doświadczenie choroby nowotworowej jest niezwykle trudnym i traumatycznym przeżyciem zarówno dla samego chorego, jak i jego bliskich. Badania z ostatnich lat wskazują, że doświadczenie traumy w wyniku choroby nowotworowej może prowadzić nie tylko do negatywnych, lecz także pozytywnych skutków definiowanych jako wzrost potraumatyczny (PTG). Cel pracy: Celem badania była próba odpowiedzi na pytanie, jaką rolę we wzroście potraumatycznym odgrywa twardość psychiczna i wsparcie społeczne oraz jaki jest związek między twardością psychiczną i wsparciem społecznym w odniesieniu do PTG. Materiał i metody: W badaniu wzięło udział 41 chorych na nowotwory powyżej 18. roku życia (M = 54,24, SD = 13,25). Badani byli leczeni w Klinice Hematologii i Transplantologii Uniwersyteckiego Centrum Klinicznego w Gdańsku oraz na Oddziale Rehabilitacji Onkologicznej Wojewódzkiego Centrum Onkologii w Gdańsku. Do przeprowadzenia badania wykorzystano następujące narzę-dzia: Inwentarz potraumatycznego rozwoju -PTGI, Skalę twardości psychicznej -HRHS oraz Berlińskie skale wsparcia społecznego -BSSS. Wyniki i wnioski: Prezentowane badanie wskazało na pozytywny wpływ wsparcia społecznego i twardości psychicznej związanej ze zdrowiem na wzrost potraumatyczny u chorych kobiet. Wsparcie społeczne pozytywnie koreluje z wynikiem ogólnym wzrostu potraumatycznego. Podobnie twardość psychiczna okazała się umiarkowanie ważnym czynnikiem dla zmian wzrostowych. Uzyskane rezultaty są wynikami wstępnymi. AbstractIntroduction: The experience of cancer is an extremely heavy and traumatic experience for both the patient and his/her loved ones. Recent studies have shown that traumatic cancer experience can lead not only to negative but also positive effects defined as posttraumatic growth (PTG). The aim of the study is to answer the question of what role is played by hardiness and social support according to PTG and what the relationship is between hardiness and social support for PTG. Material and methods: The study included 41 cancer patients over 18 years old (M = 54.24, SD = 13.25), treated at the Department of Haematology and Transplantology, UCK in Gdansk and at the Department of Oncology Rehabilitation at the Regional Centre of Oncology in Gdansk. The study was conducted using the questionnaire method with the following questionnaires: Posttrau-
StreszczenieWstęp: W procesie radzenia sobie z chorobą onkologiczną istotną rolę odgrywa wsparcie społeczne. Celem prezentowanego badania jest określenie znaczenia wsparcia, jakie pacjent daje swoim bliskim, i jaki ma ono związek z radzeniem sobie z chorobą onkologiczną oraz jakością życia. Materiał i metody: W badaniu wzięło udział 35 pacjentów powyżej 18. roku ży-cia (18 kobiet i 17 mężczyzn) z chorobą nowotworową krwi, leczonych chemioterapią i poddanych transplantacji szpiku kostnego. Badanie przeprowadzono metodą kwestionariuszową z wykorzystaniem: autorskiego kwestionariusza wsparcia otrzymywanego i dawanego, zarówno emocjonalnego, jak i instrumentalnego, Skali przystosowania psychicznego do choroby nowotworowejMini-MAC w adaptacji Z. Juczyńskiego oraz Drabiny Cantrila. Wyniki: Prezentowane badanie ukazuje korzystny obraz mechanizmu wsparcia dawanego innym w kontekście choroby nowotworowej. Wykazano istotny zwią-zek wsparcia dawanego z destruktywnymi strategiami radzenia sobie, a nie wykazano związku ze strategiami konstruktywnymi. Wyniki jakości życia wskazują na pewną niespójność. W kontekście pracy psychologicznej z pacjentami chorymi onkologicznie warto uwzględnić rolę, jaką odgrywa wsparcie, które chory daje swoim bliskim. AbstractIntroduction: In the process of coping with the oncological disease important role is played by social support. The aim of this study is to determine the importance of the role of the social support offered by the patient. Material and methods: The study included 35 patients over 18 years of age (18 women and 17 men), suffering from the blood cancer, receiving chemotherapy and treated with bone marrow transplantation. The study was conducted using the questionnaire method with the following questionnaires: author's questionnaire received and given support, both emotional and instrumental, Mental Scale Adjustment to Cancer Diseases -Mini-MAC in adaptation Z. Juczyński and Cantril Ladder.Results: The present study shows a favorable picture of the given support mechanism in the context of cancer. Given support is significantly associated with a destructive coping strategies, and it was no connection with constructive strategies. The results of the quality of life show some inconsistency. In the context of psychological work with oncological patients given support should be taken into account, the role played by the patients who give support their relatives is significantly important.
Aim of the studyThe majority of patients with chronic myeloid leukaemia (CML) respond to tyrosine kinase inhibitors (TKI), while allogeneic haematopoietic cell transplantation (HCT) is indicated in selected clinical situations. HCT carries the risk of severe complications, while the toxicity profile of dasatinib and nilotinib may lead to adverse reactions affecting the quality of life (QoL). We present the results of observational analysis of CML patients who underwent HCT after exposure to second-generation TKI (TKI2), with respect to their quality of life assessed comparatively after transplantation.Material and methodsEligible subjects included 19 patients. The quality of life and global health assessment were performed with a questionnaire comparing the signs and symptoms present during the TKI2-therapy with those related to post-transplant complications, including psychosocial problems.Results and conclusionsMost patients had no/few problems with exhausting activities, no/few difficulties during long-distance walks, and do not/rarely rest in the daytime. Seventeen (89.5%) patients reported at least one symptom related to TKI2-therapy and most of them disappeared after HCT. Thirteen (68.4%) patients noted no serious complication after HCT. Most patients claimed to have a very good QoL and general health compared to the period prior to HCT. We found statistically significant improvement in global health (p = 0.016) and QoL (p = 0.043) after HCT.From the survivors perspective, HCT influence positively general health and QoL comparing to TKI2-therapy period. Further studies on larger group of patients will more precisely define the QoL level and possible predictors of changes in QoL, to assess which group of patients needs psychological support.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.